(Q44691513)

5 December 2017

The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. (English)

1 reference

5 December 2017

Gabriela Velasco-Loyden

series ordinal

1

1 reference

5 December 2017

Joaquín Arribas

series ordinal

2

1 reference

5 December 2017

Fernando López-Casillas

series ordinal

3

1 reference

5 December 2017

language of work or name

English

0 references

publication date

12 December 2003

1 reference

Journal of Biological Chemistry

5 December 2017

1 reference

5 December 2017

279

1 reference

5 December 2017

7721-7733

1 reference

5 December 2017

9

1 reference

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

5 December 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Role of transforming growth factor beta in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Mechanism of activation of the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Expression cloning and characterization of the TGF-beta type III receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Betaglycan presents ligand to the TGF beta signaling receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Inhibin is an antagonist of bone morphogenetic protein signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Protein ectodomain shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane protein secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Impaired trafficking and activation of tumor necrosis factor-alpha-converting enzyme in cell mutants defective in protein ectodomain shedding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

A matrix metalloproteinase expressed on the surface of invasive tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane type-matrix metalloproteinases (MT-MMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Purification of ADAM 10 from bovine spleen as a TNFalpha convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

Role of the Juxtamembrane Domains of the Transforming Growth Factor-α Precursor and the β-Amyloid Precursor Protein in Regulated Ectodomain Shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306499200

21 January 2018

Identifiers

DOI

10.1074/JBC.M306499200

1 reference

5 December 2017

1 reference